Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study

Background: Dimethyl fumarate (DMF) is a disease-modifying drug for relapsing-remitting multiple sclerosis. Among others, DMF impedes immune activation by shifting the balance between inflammatory and regulatory cell types and by inducing apoptosis-triggered lymphopenia. Although the decrease in lym...

Descripción completa

Detalles Bibliográficos
Autores principales: Marastoni, Damiano, Buriani, Alessandro, Pisani, Anna Isabella, Crescenzo, Francesco, Zuco, Carmela, Fortinguerra, Stefano, Sorrenti, Vincenzo, Marenda, Bruno, Romualdi, Chiara, Magliozzi, Roberta, Monaco, Salvatore, Calabrese, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658905/
https://www.ncbi.nlm.nih.gov/pubmed/31379857
http://dx.doi.org/10.3389/fimmu.2019.01666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658905/
https://www.ncbi.nlm.nih.gov/pubmed/31379857
http://dx.doi.org/10.3389/fimmu.2019.01666

Ejemplares similares